Mölnlycke Health Care US, LLC introduces Biogel PI Pro-Fit®, a non-latex surgical glove designed to allow for a new level of comfort during surgery while reducing employee and patient health risks and costs.
Designed with a biomechanically optimized former to help prevent hand fatigue during surgery and a synthetic material that feels just as good as latex, 94 percent of surgeons surveyed rated Biogel PI (non-latex) as good as or better than Biogel Latex.
According to a recent study, there are approximately 17 operating room (OR) backtable teardowns per year on average per facility due to undetected latex allergies in patients. With Biogel PI Pro-Fit®, the OR teardown cost risk associated with glove-related patient latex allergies is eliminated.
Additionally over time, healthcare workers can develop latex sensitivity, which can average costs up to $218,000 per employee to treat their latex allergy. Biogel non-latex gloves reduce the risk of workers compensation claims and lost productivity due to staff with glove-related latex allergies being unable to work.
Biogel gloves have statistically significant fewer observed failures than other glove brands, reducing the exposure to pathogens and associated costs of treatment. In an independent observational in-use comparison study, non-Biogel gloves were 3.5 times as likely to fail in-use compared to Biogel surgical gloves.
Source: Mölnlycke Health Care US, LLC Â
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
The Critical Role of Rapid Diagnostics in Antibiotic Stewardship
November 6th 2024Rapid diagnostics enhance patient outcomes by enabling prompt, targeted treatments, reducing inappropriate antibiotic use, and combating antimicrobial resistance through informed clinical decisions and stewardship programs.